Choroidal metastasis from non-small-cell lung cancer responsive to Osimertinib: a case reportEfficacy of a third-generation epidermal growth factor tyrosine kinase inhibitor

被引：0
|
作者：
Morara Mariachiara
Ruatta Celeste
Foschi Federico
Balducci Nicole
Ciardella Antonio
机构：
[1] University of Bologna,Ophthalmology Unit, S. Orsola
[2] University of Bologna,Malpighi Hospital
来源：
International Ophthalmology | 2018年 / 38卷
关键词：
Osimertinib; Choroidal metastasis; Carcinoma; Non-small-cell lung; Receptor; Epidermal growth factor; Tyrosine kinase inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2669 / 2675
页数：6
相关论文
共 50 条
  • [1] Choroidal metastasis from non-small-cell lung cancer responsive to Osimertinib: a case report: Efficacy of a third-generation epidermal growth factor tyrosine kinase inhibitor
    Mariachiara, Morara
    Celeste, Ruatta
    Federico, Foschi
    Nicole, Balducci
    Antonio, Ciardella
    INTERNATIONAL OPHTHALMOLOGY, 2018, 38 (06) : 2669 - 2675
  • [2] EFFICACY OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR IN TREATING CHOROIDAL METASTASIS FROM NON-SMALL-CELL LUNG CANCER
    Chee, Arnold S. H.
    Mak, Andrew C. Y.
    Kam, Ka Wai
    Li, Molly S. C.
    Ho, Mary
    Brelen, Marten E.
    Chen, Li Jia
    Yip, Wilson W. K.
    Young, Alvin L.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2025, 45 (02): : 207 - 214
  • [3] Osimertinib: A third-generation tyrosine kinase inhibitor for treatment of epidermal growth factor receptor-mutated non-small cell lung cancer with the acquired Thr790Met mutation
    Bollinger, Meredith K.
    Agnew, Amanda S.
    Mascara, Gerard P.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (05) : 379 - 388
  • [4] OSIMERTINIB, A THIRD-GENERATION TYROSINE KINASE INHIBITOR TARGETING NON-SMALL CELL LUNG CANCER WITH EGFR T790M MUTATIONS
    McCoach, C. E.
    Jimeno, A.
    DRUGS OF TODAY, 2016, 52 (10) : 561 - 568
  • [5] Three Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: Similarities and Differences
    Chen, Ling
    Zhou, Yangqingqing
    Gan, Chaosheng
    Wang, XiaoLi
    Liu, Yihui
    Dong, Chunhui
    He, Ruiyuan
    Yang, Jin
    CANCER INVESTIGATION, 2022, 40 (07) : 590 - 603
  • [6] Third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer
    Pirker, Robert
    CURRENT OPINION IN ONCOLOGY, 2016, 28 (02) : 115 - 121
  • [7] Update of epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer
    Chen, Yuh-Min
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2013, 76 (05) : 249 - 257
  • [8] A Comparison Between First-, Second- and Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small-Cell Lung Cancer and Brain Metastases
    Caponnetto, Salvatore
    Cantale, Ornella
    Friedlaender, Alex
    Gomes, Fabio
    Daryanani, Sunil
    Gelibter, Alain
    Cortellini, Alessio
    Giuffrida, Dario
    Addeo, Alfredo
    Banna, Giuseppe Luigi
    JOURNAL OF MOLECULAR PATHOLOGY, 2021, 2 (01): : 1 - 10
  • [9] Exploring the mechanism of non-small-cell lung cancer cell lines resistant to epidermal growth factor receptor tyrosine kinase inhibitor
    Yu, Yongkang
    Luo, Yaohui
    Zheng, Yifeng
    Zheng, Xiushan
    Li, Wei
    Yang, Lie
    Jiang, Jianqing
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (01) : 121 - 125
  • [10] Treatment of Choroidal Metastasis from Epidermal Growth Factor Mutant Non-Small Cell Lung Cancel with First-line Osimertinib Therapy
    Vu, Anderson N.
    Mehta, Urmi, V
    Israelsen, Paul
    Ou, Hong Ignatius
    Browne, Andrew W.
    JOURNAL OF OPHTHALMIC & VISION RESEARCH, 2022, 17 (01) : 130 - 134
12345